Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3b Trial of an Adjuvanted Chikungunya Virus-like Particle Vaccine in Adolescents and Adults
TCTR20240812007Phase 3Not yet recruiting
- Sponsor
- Bavarian Nordic
- Start
- Jun 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of CHIKV VLP vaccine in Chikungunya (CHIKV), sponsored by Bavarian Nordic. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
CHIKV VLP vaccine
03
Conditions
Chikungunya (CHIKV)
Beyond the preview
Go deeper on TCTR20240812007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240812007.